Metropolitan Life Insurance CO Sage Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

52 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$16.75 - $48.98 $2,311 - $6,759	138 Added 4.77%	3,029 $62,000
Q1 2023 May 15, 2023	SELL	$37.27 - $46.57 $9,578 - $11,968	-257 Reduced 8.16%	2,891 $121,000
Q4 2022 Jun 14, 2023	BUY	$32.2 - $43.61 $8,275 - $11,207	257 Added 8.89%	3,148 $120 Million
Q3 2022 Jun 14, 2023	BUY	$32.28 - $43.27 $8,295 - $11,120	257 Added 8.89%	3,148 $123 Million
Q2 2022 Jun 20, 2023	BUY	$27.52 - $37.99 $7,072 - $9,763	257 Added 8.89%	3,148 $101,000
Q2 2022 Mar 30, 2023	BUY	$27.52 - $37.99 $58,452 - $80,690	2,124 Added 207.42%	3,148 $101,000
Q2 2022 Aug 11, 2022	BUY	$27.52 - $37.99 $86,632 - $119,592	3,148 New	3,148 $102,000
Q1 2022 May 12, 2022	SELL	$30.71 - $45.71 $31,447 - $46,807	-1,024 Closed	0 $0
Q4 2021 Jun 21, 2023	SELL	$37.06 - $47.11 $69,191 - $87,954	-1,867 Reduced 64.58%	1,024 $43,000
Q4 2021 Mar 30, 2023	SELL	$37.06 - $47.11 $1,408 - $1,790	-38 Reduced 3.58%	1,024 $43,000
Q4 2021 Feb 15, 2022	BUY	$37.06 - $47.11 $37,949 - $48,240	1,024 New	1,024 $44,000
Q3 2021 Jun 21, 2023	SELL	$40.26 - $57.37 $75,286 - $107,281	-1,870 Reduced 64.68%	1,021 $45.2 Million
Q3 2021 Nov 15, 2021	SELL	$40.26 - $57.37 $42,756 - $60,926	-1,062 Closed	0 $0
Q2 2021 Jun 21, 2023	SELL	$54.88 - $79.29 $100,375 - $145,021	-1,829 Reduced 63.27%	1,062 $60,000
Q2 2021 Mar 30, 2023	BUY	$54.88 - $79.29 $43,190 - $62,401	787 Added 286.18%	1,062 $60,000
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $58,282 - $84,205	1,062 New	1,062 $60,000
Q1 2021 Jun 26, 2023	SELL	$70.65 - $96.76 $117,067 - $160,331	-1,657 Reduced 57.32%	1,234 $92.4 Million
Q1 2021 Mar 30, 2023	SELL	$70.65 - $96.76 $65,987 - $90,373	-934 Reduced 77.25%	275 $20,000
Q1 2021 May 14, 2021	SELL	$70.65 - $96.76 $85,415 - $116,982	-1,209 Closed	0 $21,000
Q4 2020 Jun 22, 2023	SELL	$58.41 - $89.06 $98,245 - $149,798	-1,682 Reduced 58.18%	1,209 $104,000
Q4 2020 Mar 30, 2023	SELL	$58.41 - $89.06 $2,044 - $3,117	-35 Reduced 2.81%	1,209 $104,000
Q4 2020 Feb 16, 2021	SELL	$58.41 - $89.06 $2,044 - $3,117	-35 Reduced 2.81%	1,209 $105,000
Q3 2020 Jun 26, 2023	SELL	$41.13 - $62.45 $67,741 - $102,855	-1,647 Reduced 56.97%	1,244 $76,000
Q3 2020 Mar 30, 2023	SELL	$41.13 - $62.45 $822 - $1,249	-20 Reduced 1.58%	1,244 $76,000
Q3 2020 Nov 13, 2020	SELL	$41.13 - $62.45 $822 - $1,249	-20 Reduced 1.58%	1,244 $76,000
Q2 2020 Jun 26, 2023	SELL	$25.95 - $43.15 $42,220 - $70,205	-1,627 Reduced 56.28%	1,264 $52,000
Q2 2020 Mar 30, 2023	SELL	$25.95 - $43.15 $60,152 - $100,021	-2,318 Reduced 64.71%	1,264 $52,000
Q2 2020 Aug 14, 2020	SELL	$25.95 - $43.15 $60,152 - $100,021	-2,318 Reduced 64.71%	1,264 $53,000
Q1 2020 Jul 12, 2023	BUY	$26.15 - $77.24 $18,069 - $53,372	691 Added 23.9%	3,582 $102,000
Q1 2020 Mar 30, 2023	SELL	$26.15 - $77.24 $2,954 - $8,728	-113 Reduced 3.06%	3,582 $102,000
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $2,954 - $8,728	-113 Reduced 3.06%	3,582 $103,000
Q4 2019 Jul 12, 2023	BUY	$60.18 - $154.77 $48,384 - $124,435	804 Added 27.81%	3,695 $266,000
Q4 2019 Mar 30, 2023	SELL	$60.18 - $154.77 $1,203 - $3,095	-20 Reduced 0.54%	3,695 $266,000
Q4 2019 Feb 14, 2020	SELL	$60.18 - $154.77 $1,203 - $3,095	-20 Reduced 0.54%	3,695 $267,000
Q3 2019 Jul 12, 2023	BUY	$140.29 - $189.96 $115,598 - $156,527	824 Added 28.5%	3,715 $521,000
Q3 2019 Mar 30, 2023	BUY	$140.29 - $189.96 $17,957 - $24,314	128 Added 3.57%	3,715 $521,000
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $17,957 - $24,314	128 Added 3.57%	3,715 $521,000
Q2 2019 Jul 12, 2023	BUY	$157.85 - $183.09 $109,863 - $127,430	696 Added 24.07%	3,587 $656,000
Q2 2019 Mar 30, 2023	SELL	$157.85 - $183.09 $13,101 - $15,196	-83 Reduced 2.26%	3,587 $656,000
Q2 2019 Aug 14, 2019	SELL	$157.85 - $183.09 $13,101 - $15,196	-83 Reduced 2.26%	3,587 $657,000
Q1 2019 Jul 13, 2023	BUY	$89.33 - $163.65 $69,588 - $127,483	779 Added 26.95%	3,670 $583,000
Q1 2019 Mar 30, 2023	BUY	$89.33 - $163.65 $46,630 - $85,425	522 Added 16.58%	3,670 $583,000
Q1 2019 May 16, 2019	BUY	$89.33 - $163.65 $197,687 - $362,157	2,213 Added 151.89%	3,670 $583,000
Q1 2019 May 15, 2019	SELL	$89.33 - $163.65 $182,143 - $333,682	-2,039 Reduced 58.32%	1,457 $64,000
Q4 2018 Jul 13, 2023	BUY	$81.94 - $139.71 $49,573 - $84,524	605 Added 20.93%	3,496 $334,000
Q4 2018 Feb 14, 2019	SELL	$81.94 - $139.71 $983 - $1,676	-12 Reduced 0.34%	3,496 $335,000
Q3 2018 Jul 13, 2023	BUY	$138.11 - $169.04 $85,213 - $104,297	617 Added 21.34%	3,508 $496 Million
Q3 2018 Nov 14, 2018	SELL	$138.11 - $169.04 $9,529 - $11,663	-69 Reduced 1.93%	3,508 $496,000
Q2 2018 Aug 15, 2018	SELL	$140.36 - $175.76 $1.33 Million - $1.67 Million	-9,489 Reduced 72.62%	3,577 $0
Q1 2018 May 15, 2018	BUY	$152.15 - $192.33 $199,925 - $252,721	1,314 Added 11.18%	13,066 $0
Q4 2017 Feb 15, 2018	SELL	$60.72 - $167.34 $710,424 - $1.96 Million	-11,700 Reduced 49.89%	11,752 $1.94 Million
Q2 2017 Aug 14, 2017	BUY	N/A	23,452	23,452 $1.87 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account